January 8, 2021
The Pharmaceuticals and Medical Devices Agency (PMDA) has revised the label of Gilead Sciences’ antiviral agent Veklury (remdesivir) to allow its use not only in severe COVID-19 cases but also in moderately ill patients. With the drug’s supplies to Japan...read more